Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > NEWS debt repayment 5 cent valuation....

<< Previous

Bullboard Posts

Next >>

Comment by Magnum2on May 30, 2020 1:12pm

124 Views

Post# 31091949

RE:RE:RE:RE:NEWS debt repayment 5 cent valuation....

Just pointing out that cheap paper has been issued and sooner or later is does have to be chewed thru.

What is more troublesome, and appears is still ahead is this CFO departure and a $2.5 Million/share settlement.

So add Cooks debt settlement and the CFO lawsuit settlement and now that is $3.3 Million that a microcap had to anti up...not sure what their sales/earnings per year are, but I expect this is going backwards and not forwards/building equity for shareholders.

I will let you decide what these shares are worth, you do not want my opinion.

GLTA

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?